Zur Rose group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group

Internet & Digital Media

Zur Rose group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group

  • Client:

    FirstCapital’s partner ACXIT Capital Partners advised Zur Rose on the acquisition of Apotal Group.

  • Result:

    Expanding the client base to more than 8 million active customers will solidify the market leadership of Zur Rose Group in Europe significantly. Increasing scaling benefits will enhance and leverage the implementation of digital health services including the electronic prescription as well as the e-health platform.